content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Opexa Therapeutic, Inc. (OPXA)

0.98
0.02
(1.90%)
Sep 11, 3:58PM EDT
content_middle

Opexa Therapeutics (OPXA), a biopharmaceutical company, develops personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. OPXA was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics in June 2006 < founded in 2003> and is based in The Woodlands, Texas.

Previous Close: 
0.96
Open: 
0.94
Bid: 
0.80
Ask: 
0.99
1yr Target Price: 
1.00
Day's Range: 
0.94 - 0.98
52wk Range: 
0.50 - 4.38
Volume: 
135368
Average Daily Volume: 
500911
Market Capitalization: 
7.49M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
7657000M
content_right

Pages